News
The agency's Digital Health Advisory Committee will meet on November 6 and focus on how these digital tools could help ...
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug ...
The FDA is moving to scale back its long-standing use of expert panels to review drug applications, KFF Health News reported Sept. 12. George Tidmarsh, MD, PhD, director of the FDA’s Center for Drug ...
Amid ongoing upheaval at the FDA and other federal health agencies, prominent vaccine expert and Robert F. Kennedy Jr. critic ...
9d
MedPage Today on MSNFDA Pulls RFK Jr. Critic Off Its Vaccine Advisory Panel
Pediatric vaccine expert Paul Offit, MD, a longtime critic of HHS Secretary Robert F. Kennedy Jr., has been removed from the ...
Doctors recommend vaccination,” Stein says. The FDA recommended new COVID vaccines for people 65 and up or with a high-risk ...
3d
Stocktwits on MSNTravere Therapeutics Stock Soars Pre-market After FDA Waives Need For An Advisory Committee Meeting On Its Kidney Disorder Drug Application
Travere Therapeutics (TVTX) on Wednesday said that the U.S. Food and Drug Administration informed the company that it has ...
Ocaliva won accelerated approval for primary biliary cholangitis in 2016, which the FDA refused to upgrade to full approval ...
The FDA will convene its Digital Health Advisory Committee Nov. 6 to discuss the use of generative artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results